Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04474470 |
|---|---|
| Brief Title: | A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer |
| First Submitted : | June 30, 2020 |
| First Submitted that Met QC Criteria : | July 13, 2020 |
| First Posted : | July 16, 2020 |
| Last Update Submitted that Met QC Criteria : | May 8, 2024 |
| Last Update Posted : | May 9, 2024 |